Circulation, Vol 89, 2204-2211, Copyright © 1994 by American Heart Association
M Kojima, I Shiojima, T Yamazaki, I Komuro, Z Zou, Y Wang, T Mizuno, K Ueki, K Tobe and T Kadowaki
BACKGROUND: Previous studies have demonstrated that angiotensin II (Ang II)
acts as a growth-promoting factor directly on cardiac myocytes and that
angiotensin-converting enzyme inhibitor induces regression of hypertrophied
hearts both in experimental animals and in humans. These results suggest
that the renin-angiotensin system (RAS) is involved in the formation of
left ventricular hypertrophy (LVH). To elucidate the role of RAS in the
progression of cardiac hypertrophy, we evaluated the effect of an Ang II
receptor antagonist on LVH in spontaneously hypertensive rats (SHRs) and
investigated the molecular mechanisms by which antagonizing Ang II
receptors reduces cell hypertrophy of myocytes using the in vitro model of
mechanical stretch. METHODS AND RESULTS: In the in vivo study, we treated
SHRs with the nonpeptide Ang II receptor antagonist TCV-116 (0.1, 1, or 10
mg/kg per day) or hydralazine (10 mg/kg per day). Blood pressure was
measured by the tail- cuff method, and wall thickness of left ventricle was
serially monitored using M-mode echocardiography. Rats were killed at the
age of 13, 17, 21, or 25 weeks, and left ventricular (LV) weight,
transverse diameter of cardiomyocytes, relative amount of V3 myosin heavy
chain (MHC), and degree of interstitial collagen accumulation were
examined. Untreated SHRs progressively developed severe hypertension, but
treatment with TCV-116 or hydralazine inhibited the increase in blood
pressure. Treatment with TCV-116 reduced LV weight, LV wall thickness,
transverse diameter of myocytes, relative amount of V3 MHC, and
interstitial fibrosis, whereas treatment with hydralazine slightly
prevented an increase in LV wall thickness but did not exert significant
reduction in other parameters. In the in vitro study, neonatal rat
cardiomyocytes were cultured on deformable silicone dishes and mechanically
stretched with or without pretreatment of CV-11974 (an active metabolite of
TCV-116), and [3H]phenylalanine incorporation, activity of
mitogen-activated protein (MAP) kinase, and c-fos mRNA expression were
analyzed. Pretreatment of cultured cardiomyocytes with 10(-7) mol/L
CV-11974 inhibited an increase in [3H]phenylalanine incorporation, MAP
kinase activity, and c-fos gene expression induced by stretch of
cardiomyocytes. CONCLUSIONS: The Ang II receptor antagonist TCV-116 induced
regression of cardiac hypertrophy and had cardioprotective effects on
hypertrophied myocardium in vivo, and antagonizing Ang II receptors
inhibited intracellular signaling of stretch-mediated cardiomyocyte
hypertrophy in vitro. These results suggest a crucial role of the cardiac
RAS in the development of LVH produced by pressure overload.
ARTICLES
Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro
Department of Medicine III, Tokyo University School of Medicine, Japan.
This article has been cited by other articles:
![]() |
M. Sakamoto, T. Minamino, H. Toko, Y. Kayama, Y. Zou, M. Sano, E. Takaki, T. Aoyagi, K. Tojo, N. Tajima, et al. Upregulation of Heat Shock Transcription Factor 1 Plays a Critical Role in Adaptive Cardiac Hypertrophy Circ. Res., December 8, 2006; 99(12): 1411 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta, D. Young, and S. Sen Inhibition of NF-{kappa}B induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H20 - H29. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rosenkranz TGF-{beta}1 and angiotensin networking in cardiac remodeling Cardiovasc Res, August 15, 2004; 63(3): 423 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yasunari, K. Maeda, T. Watanabe, M. Nakamura, J. Yoshikawa, and A. Asada Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2116 - 2123. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Niu, T. Shindo, H. Iwata, S. Iimuro, N. Takeda, Y. Zhang, A. Ebihara, Y. Suematsu, K. Kangawa, Y. Hirata, et al. Protective Effects of Endogenous Adrenomedullin on Cardiac Hypertrophy, Fibrosis, and Renal Damage Circulation, April 13, 2004; 109(14): 1789 - 1794. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Otsuka, H Takahashi, M Shiratori, H Chiba, and S Abe Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist Thorax, January 1, 2004; 59(1): 31 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sato, H. Yaoita, K. Maehara, and Y. Maruyama Attenuation of heart failure due to coronary stenosis by ACE inhibitor and angiotensin receptor blocker Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H359 - H368. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shiojima, M. Yefremashvili, Z. Luo, Y. Kureishi, A. Takahashi, J. Tao, A. Rosenzweig, C. R. Kahn, E. D. Abel, and K. Walsh Akt Signaling Mediates Postnatal Heart Growth in Response to Insulin and Nutritional Status J. Biol. Chem., September 27, 2002; 277(40): 37670 - 37677. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nagata, F. Somura, K. Obata, M. Odashima, H. Izawa, S. Ichihara, T. Nagasaka, M. Iwase, Y. Yamada, N. Nakashima, et al. AT1 Receptor Blockade Reduces Cardiac Calcineurin Activity in Hypertensive Rats Hypertension, August 1, 2002; 40(2): 168 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kobayashi, S. Nakano, S.-i. Mita, T. Kobayashi, T. Honda, Y. Tsubokou, and H. Matsuoka Involvement of Rho-Kinase Pathway for Angiotensin II-Induced Plasminogen Activator Inhibitor-1 Gene Expression and Cardiovascular Remodeling in Hypertensive Rats J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 459 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iemitsu, T. Miyauchi, S. Maeda, S. Sakai, T. Kobayashi, N. Fujii, H. Miyazaki, M. Matsuda, and I. Yamaguchi Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R2029 - R2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kamogawa, S. Biro, M. Maeda, M. Setoguchi, T. Hirakawa, H. Yoshida, and C. Tei Dystrophin-deficient myocardium is vulnerable to pressure overload in vivo Cardiovasc Res, June 1, 2001; 50(3): 509 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tamura, S. Said, J. Harris, W. Lu, and A. M. Gerdes Reverse Remodeling of Cardiac Myocyte Hypertrophy in Hypertension and Failure by Targeting of the Renin-Angiotensin System Circulation, July 11, 2000; 102(2): 253 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G Brilla Renin-angiotensin-aldosterone system and myocardial fibrosis Cardiovasc Res, July 1, 2000; 47(1): 1 - 3. [Full Text] [PDF] |
||||
![]() |
C. Ruwhof and A. van der Laarse Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways Cardiovasc Res, July 1, 2000; 47(1): 23 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G Brilla Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs Cardiovasc Res, May 1, 2000; 46(2): 324 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G Stanley, H. Patel, A. L Knight, and B. Williams Mechanical strain-induced human vascular matrix synthesis: The role of angiotensin II Journal of Renin-Angiotensin-Aldosterone System, March 1, 2000; 1(1): 32 - 35. [Abstract] [PDF] |
||||
![]() |
M. Shimoyama, D. Hayashi, E. Takimoto, Y. Zou, T. Oka, H. Uozumi, S. Kudoh, F. Shibasaki, Y. Yazaki, R. Nagai, et al. Calcineurin Plays a Critical Role in Pressure Overload-Induced Cardiac Hypertrophy Circulation, December 14, 1999; 100(24): 2449 - 2454. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Makino, M. Sugano, S. Ohtsuka, S. Sawada, and T. Hata Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats Cardiovasc Res, December 1, 1999; 44(3): 543 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kim, T. Lee, J. Fu, and M. E. Ritchie Characterization of MAP kinase and PKC isoform and effect of ACE inhibition in hypertrophy in vivo Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1808 - H1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Dostal and K. M. Baker The Cardiac Renin-Angiotensin System : Conceptual, or a Regulator of Cardiac Function? Circ. Res., October 1, 1999; 85(7): 643 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jalili, Y. Takeishi, and R. A Walsh Signal transduction during cardiac hypertrophy: the role of G{alpha}q, PLC {beta}I, and PKC Cardiovasc Res, October 1, 1999; 44(1): 5 - 9. [Full Text] [PDF] |
||||
![]() |
F. Brunner Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat Cardiovasc Res, October 1, 1999; 44(1): 197 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C Wollert and H. Drexler The renin-angiotensin system and experimental heart failure Cardiovasc Res, September 1, 1999; 43(4): 838 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamamoto, Q. N. Dang, S. P. Kennedy, R. Osathanondh, R. A. Kelly, and R. T. Lee Induction of Tenascin-C in Cardiac Myocytes by Mechanical Deformation. ROLE OF REACTIVE OXYGEN SPECIES J. Biol. Chem., July 30, 1999; 274(31): 21840 - 21846. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ogino, B. Cai, A. Gu, T. Kohmoto, N. Yamamoto, and D. Burkhoff Factors contributing to pressure overload-induced immediate early gene expression in adult rat hearts in vivo Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H380 - H387. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tanimura, V. G. Sharov, H. Shimoyama, T. Mishima, T. B. Levine, S. Goldstein, and H. N. Sabbah Effects of AT1-receptor blockade on progression of left ventricular dysfunction in dogs with heart failure Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1385 - H1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fujii, S. Umemoto, A. Fujii, T. Yonezawa, T. Sakumura, and M. Matsuzaki Angiotensin II Type 1 Receptor Antagonist Downregulates Nonmuscle Myosin Heavy Chains in Spontaneously Hypertensive Rat Aorta Hypertension, April 1, 1999; 33(4): 975 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Thurmann, P. Kenedi, A. Schmidt, S. Harder, and N. Rietbrock Influence of the Angiotensin II Antagonist Valsartan on Left Ventricular Hypertrophy in Patients With Essential Hypertension Circulation, November 10, 1998; 98(19): 2037 - 2042. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Cingolani, B. V. Alvarez, I. L. Ennis, and M. C. Camilion de Hurtado Stretch-Induced Alkalinization of Feline Papillary Muscle : An Autocrine-Paracrine System Circ. Res., October 19, 1998; 83(8): 775 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yano, S. Kim, Y. Izumi, S. Yamanaka, and H. Iwao Differential Activation of Cardiac c-Jun Amino-Terminal Kinase and Extracellular Signal-Regulated Kinase in Angiotensin II–Mediated Hypertension Circ. Res., October 5, 1998; 83(7): 752 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hu, P. Gaudron, H.-J. Anders, F. Weidemann, O. Turschner, M. Nahrendorf, and G. Ertl Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin Cardiovasc Res, August 1, 1998; 39(2): 401 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mazzolai, J. Nussberger, J.-F. Aubert, D. B. Brunner, G. Gabbiani, H. R. Brunner, and T. Pedrazzini Blood Pressure–Independent Cardiac Hypertrophy Induced by Locally Activated Renin-Angiotensin System Hypertension, June 1, 1998; 31(6): 1324 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Harada, I. Komuro, I. Shiojima, D. Hayashi, S. Kudoh, T. Mizuno, K. Kijima, H. Matsubara, T. Sugaya, K. Murakami, et al. Pressure Overload Induces Cardiac Hypertrophy in Angiotensin II Type 1A Receptor Knockout Mice Circulation, May 19, 1998; 97(19): 1952 - 1959. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamamoto, Q. N. Dang, R. A. Kelly, and R. T. Lee Mechanical Strain Suppresses Inducible Nitric-oxide Synthase in Cardiac Myocytes J. Biol. Chem., May 8, 1998; 273(19): 11862 - 11866. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sakata, B. D. Hoit, S. B. Liggett, R. A. Walsh, and G. W. Dorn II Decompensation of Pressure-Overload Hypertrophy in G{alpha}q-Overexpressing Mice Circulation, April 21, 1998; 97(15): 1488 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamazaki, I. Komuro, S. Kudoh, Y. Zou, R. Nagai, R. Aikawa, H. Uozumi, and Y. Yazaki Role of Ion Channels and Exchangers in Mechanical Stretch–Induced Cardiomyocyte Hypertrophy Circ. Res., March 9, 1998; 82(4): 430 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zou, I. Komuro, T. Yamazaki, S. Kudoh, R. Aikawa, W. Zhu, I. Shiojima, Y. Hiroi, K. Tobe, T. Kadowaki, et al. Cell Type–Specific Angiotensin II–Evoked Signal Transduction Pathways : Critical Roles of Gß{gamma} Subunit, Src Family, and Ras in Cardiac Fibroblasts Circ. Res., February 23, 1998; 82(3): 337 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A.A. van Heugten, M. C. van Setten, K. Eizema, P. D. Verdouw, and J. M.J. Lamers Sarcoplasmic reticulum Ca2+ ATPase promoter activity during endothelin-1 induced hypertrophy of cultured rat cardiomyocytes Cardiovasc Res, February 1, 1998; 37(2): 503 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wharton, K. Morgan, R. A. D. Rutherford, J. D. Catravas, A. Chester, B. F. Whitehead, M. R. D. Leval, M. H. Yacoub, and J. M. Polak Differential Distribution of Angiotensin AT2 Receptors in the Normal and Failing Human Heart J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 323 - 336. [Abstract] [Full Text] |
||||
![]() |
T. Yamazaki, I. Komuro, Y. Zou, S. Kudoh, I. Shiojima, T. Mizuno, Y. Hiroi, R. Nagai, and Y. Yazaki Efficient Inhibition of the Development of Cardiac Remodeling by a Long-Acting Calcium Antagonist Amlodipine Hypertension, January 1, 1998; 31(1): 32 - 38. [Abstract] [Full Text] |
||||
![]() |
Y. Izumi, S. Kim, T. Murakami, S. Yamanaka, and H. Iwao Cardiac Mitogen-Activated Protein Kinase Activities Are Chronically Increased in Stroke-Prone Hypertensive Rats Hypertension, January 1, 1998; 31(1): 50 - 56. [Abstract] [Full Text] |
||||
![]() |
J. Magga, O. Vuolteenaho, M. Marttila, and H. Ruskoaho Endothelin-1 Is Involved in Stretch-Induced Early Activation of B-Type Natriuretic Peptide Gene Expression in Atrial but Not in Ventricular Myocytes : Acute Effects of Mixed ETA/ETB and AT1 Receptor Antagonists In Vivo and In Vitro Circulation, November 4, 1997; 96(9): 3053 - 3062. [Abstract] [Full Text] |
||||
![]() |
J. L. Segar, T. D. Scholz, K. A. Bedell, O. M. Smith, D. J. Huss, and E. N. Guillery Angiotensin AT1 receptor blockade fails to attenuate pressure-overload cardiac hypertrophy in fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1501 - R1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Obayashi, M. Yano, M. Kohno, S. Kobayashi, T. Tanigawa, K. Hironaka, T. Ryouke, and M. Matsuzaki Dose-dependent effect of ANG II-receptor antagonist on myocyte remodeling in rat cardiac hypertrophy Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1824 - H1831. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Makino, M. Sugano, S. Otsuka, and T. Hata Molecular Mechanism of Angiotensin II Type I and Type II Receptors in Cardiac Hypertrophy of Spontaneously Hypertensive Rats Hypertension, October 1, 1997; 30(4): 796 - 802. [Abstract] [Full Text] |
||||
![]() |
E. O. Weinberg, M. A. Lee, M. Weigner, K. Lindpaintner, S. P. Bishop, C. R. Benedict, K. K. L. Ho, P. S. Douglas, E. Chafizadeh, and B. H. Lorell Angiotensin AT1 Receptor Inhibition : Effects on Hypertrophic Remodeling and ACE Expression in Rats With Pressure-Overload Hypertrophy due to Ascending Aortic Stenosis Circulation, March 18, 1997; 95(6): 1592 - 1600. [Abstract] [Full Text] |
||||
![]() |
T. Yamazaki, I. Komuro, Y. Zou, S. Kudoh, I. Shiojima, Y. Hiroi, T. Mizuno, R. Aikawa, H. Takano, and Y. Yazaki Norepinephrine Induces the raf-1 Kinase/Mitogen-Activated Protein Kinase Cascade Through Both {alpha}1- and ß-Adrenoceptors Circulation, March 4, 1997; 95(5): 1260 - 1268. [Abstract] [Full Text] |
||||
![]() |
S. Kudoh, I. Komuro, T. Mizuno, T. Yamazaki, Y. Zou, I. Shiojima, N. Takekoshi, and Y. Yazaki Angiotensin II Stimulates c-Jun NH2-Terminal Kinase in Cultured Cardiac Myocytes of Neonatal Rats Circ. Res., January 1, 1997; 80(1): 139 - 146. [Abstract] [Full Text] |
||||
![]() |
F. Elijovich, H.-W. Zhao, C. L. Laffer, Y. Du, D. J. DiPette, T. Inagami, and D. H. Wang Regulation of Growth of the Adrenal Gland in DOC-Salt Hypertension: Role of Angiotensin II Receptor Subtypes Hypertension, January 1, 1997; 29(1): 408 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zou, I. Komuro, T. Yamazaki, R. Aikawa, S. Kudoh, I. Shiojima, Y. Hiroi, T. Mizuno, and Y. Yazaki Protein Kinase C, but Not Tyrosine Kinases or Ras, Plays a Critical Role in Angiotensin II-induced Activation of Raf-1 Kinase and Extracellular Signal-regulated Protein Kinases in Cardiac Myocytes J. Biol. Chem., December 27, 1996; 271(52): 33592 - 33597. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kobayashi, M. Yano, M. Kohno, M. Obayashi, Y. Hisamatsu, T. Ryoke, T. Ohkusa, K. Yamakawa, and M. Matsuzaki Influence of Aortic Impedance on the Development of Pressure-Overload Left Ventricular Hypertrophy in Rats Circulation, December 15, 1996; 94(12): 3362 - 3368. [Abstract] [Full Text] |
||||
![]() |
R. M. Touyz, J. Fareh, G. Thibault, and E. L. Schiffrin Intracellular Ca2+ Modulation by Angiotensin II and Endothelin-1 in Cardiomyocytes and Fibroblasts From Hypertrophied Hearts of Spontaneously Hypertensive Rats Hypertension, November 1, 1996; 28(5): 797 - 805. [Abstract] [Full Text] |
||||
![]() |
K. Kijima, H. Matsubara, S. Murasawa, K. Maruyama, Y. Mori, N. Ohkubo, I. Komuro, Y. Yazaki, T. Iwasaka, and M. Inada Mechanical Stretch Induces Enhanced Expression of Angiotensin II Receptor Subtypes in Neonatal Rat Cardiac Myocytes Circ. Res., October 1, 1996; 79(4): 887 - 897. [Abstract] [Full Text] |
||||
![]() |
D. Susic, E. Nunez, E. D. Frohlich, and O. Prakash |